| Symbol | KLRA |
|---|---|
| Name | KAILERA THERAPEUTICS, INC. |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Pharmaceutical Preparations |
| Address | 180 THIRD AVENUE, WALTHAM, MA 02451 |
| Telephone | 508-440-9475 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0002096997 |
| Description | None |
New Form SCHEDULE 13G - Kailera Therapeutics, Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001193125-26-352133 <b>Size:</b> 18 KB
Read moreNew Form SCHEDULE 13G - Kailera Therapeutics, Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001493215-26-000151 <b>Size:</b> 12 KB
Read more(30% Negative) KAILERA THERAPEUTICS, INC. (KLRA) Reports Q3 2026 Financial Results
Read moreTregoning Kathleen 🟢 acquired 175.0K shares (1 derivative) of Kailera Therapeutics, Inc. (KLRA) at $23.30 ($4.1M) Transaction Date: Jul 06, 2026 | Filing ID: 298558
Read moreNew Form 3 - Kailera Therapeutics, Inc. <b>Filed:</b> 2026-07-08 <b>AccNo:</b> 0001193125-26-298547 <b>Size:</b> 22 KB
Read moreKailera Therapeutics Appoints Kathleen Tregoning as Chief Corporate Affairs Officer
Read moreRenaud Ronald C JR 🟡 adjusted position in 0 shares (1 derivative) of Kailera Therapeutics, Inc. (KLRA) at $5.25 Transaction Date: Jun 09, 2026 | Filing ID: 267493
Read moreHengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026
Read more(30% Negative) KAILERA THERAPEUTICS, INC. (KLRA) Reports Q2 2026 Financial Results
Read moreKailera Reports First Quarter 2026 Financial Results and Provides Clinical Data Updates
Read more